Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    UroGen Pharma Ltd.

    NASDAQ: URGN · Real-Time Price · USD
    19.42
    -0.29 (-1.47%)
    At close: Aug 18, 2025, 3:59 PM
    19.11
    -1.60%
    Pre-market: Aug 19, 2025, 04:23 AM EDT

    UroGen Pharma Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 90.4M 82.71M 64.36M 48.04M
    Cost of Revenue
    		 8.88M 9.36M 7.65M 5.16M
    Gross Profit
    		 81.52M 73.35M 56.7M 42.88M
    Operating Income
    		 -96.78M -65.54M -79.04M -92.29M
    Interest Income
    		 8.9M 2.64M 938K 365K
    Pretax Income
    		 -124.04M -98.32M -108.03M -109.37M
    Net Income
    		 -126.87M -102.24M -109.78M -110.82M
    Selling & General & Admin
    		 121.15M 93.27M 82.84M 87.53M
    Research & Development
    		 57.15M 45.61M 52.91M 47.64M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 178.3M 138.89M 135.74M 135.18M
    Interest Expense
    		 12.52M 14.71M 8.44M 17.44M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 187.18M 148.25M 143.4M 140.33M
    Income Tax Expense
    		 2.83M 3.92M 1.75M 1.45M
    Shares Outstanding (Basic)
    		 42.88M 28.83M 22.81M 22.35M
    Shares Outstanding (Diluted)
    		 42.88M 28.83M 22.81M 22.35M
    EPS (Basic)
    		 -2.96 -3.55 -4.79 -4.96
    EPS (Diluted)
    		 -2.96 -3.55 -4.79 -4.96
    EBITDA
    		 -110.33M -60.35M -76.21M -90.15M
    EBIT
    		 -88.11M -62.06M -78.03M -91.93M
    Depreciation & Amortization
    		 1.19M 1.71M 1.82M 1.77M

    Add to Watchlist